A single rapid point-of-care placental growth factor determination as an aid in the diagnosis of preeclampsia

Pregnancy Hypertension

Volumn 2, Issue 1, 2012, Pages 8-15

  Knudsen, Ulla B ^a   Kronborg, Camilla S ^a   Von Dadelszen, Peter ^b   Kupfer, Ken ^c   Lee, Seok Won ^c   Vittinghus, Erik ^a   Allen, Jim G ^a   Redman, Christopher W ^d  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Alere   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Angiogenesis; Biomarkers; PlGF; Preeclampsia; Preterm preeclampsia; Triage PLGF test

Indexed keywords

EDETIC ACID; PLACENTAL GROWTH FACTOR;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DELIVERY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; FEMALE; FLUORESCENCE IMMUNOASSAY; GESTATIONAL AGE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; PARITY; POINT OF CARE TESTING; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

EID: 83555176118     PISSN: 22107789     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.preghy.2011.08.117     Document Type: Article

References (21)

1. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1-22.
2. E.A. Steegers, P. von Dadelszen, J.J. Duvekot, and R. Pijnenborg Pre-eclampsia Lancet 376 9741 2010 631 644
3. C.W. Redman, and I.L. Sargent Placental stress and preeclampsia: a revised view Placenta 30 Suppl. A 2009 S38 S42
4. D.A. Davey, and I. MacGillivray The classification and definition of the hypertensive disorders of pregnancy Am J Obstet Gynecol 158 1988 892 898
5. Jun Zhang, Jonathan Zeisler, Maureen C. Hatch, and Gertrud Berkowitz Epidemiology of pregnancy-induced hypertension Epidemiol Rev 19 1997 218 231
6. C.M. Koopmans, D. Bijlenga, H. Groen, S.M. Vijgen, J.G. Aarnoudse, and D.J. Bekedam Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial Lancet 374 9694 2009 979 988
7. L.A. Magee, P.J. Yong, V. Espinosa, A.M. Cote, I. Chen, and P. von Dadelszen Expectant management of severe preeclampsia remote from term: a structured systematic review Hypertens Pregnancy 28 2009 312 347
8. C.W. Redman, and I.L. Sargent Latest advances in understanding preeclampsia Science 308 2005 1592 1594 (Pubitemid 40807500)
9. R.J. Levine, S.E. Maynard, and C. Qian Circulating angiogenic factors and the risk for preeclampsia N Engl J Med 350 2004 672 683 (Pubitemid 38364626)
10. R. Romero, J.K. Nien, and J. Espinoza A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble VEGF receptor-1) factors in control pregnancy and patients destined to develop preeclampsia and deliver a small-for-gestational-age neonate J Matern Fetal Neonatal Med 21 2008 9 23
11. S. Sunderji, E. Gaziano, and D. Wothe Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study Am J Obstet Gynecol 202 2010 40 47
12. C. Lam, K. Lim, and S.A. Karumanchi Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia Hypertension 46 2005 1077 1085 (Pubitemid 41533005)
13. M. Shorkry, M.A. Bedaiwy, M.M.F. Fathalla, A. Alsemary, S. Elwakil, and A. Murphy Maternal serum placental growth factor and soluble fms-like tyrosine kinase 1 as early predictors of preeclampsia Acta Obstet Gynecol 89 2010 43 46
14. J.A. Hanley, and B.J. McNeil The meaning and use of the area under a receiver operating characteristic (ROC) curve Radiology 143 1982 29 36 (Pubitemid 12142173)
15. B.M. Sibai, B.M. Mercer, E. Schiff, and S.A. Friedman Aggressive versus expectant management of severe preeclampsia 28 to 32 weeks gestation: a randomized controlled trial Am J Obstet Gynecol 171 1994 818 822 (Pubitemid 24312370)
16. C. Hirashima, A. Ohkuchi, F. Arai, K. Takahashi, H. Suzuki, and T. Watanabe Establishing reference values for both total soluble Fms-like tyrosine kinase 1 and free placental growth factor in pregnant women Hypertens Res. 28 2005 727 732 (Pubitemid 41723531)
17. A. Ohkuchi, C. Hirashima, and H. Suzuki Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia Hypertens Res 33 5 2010 422 427 10.1038/hr.2010.15
18. S.J. Benton, Y. Hu, F. Xie, K. Kupfer, S.W. Lee, and L.A. Magee Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays Am J Obstet Gynecol 2011 10.1016/j.ajog.2011.06.058
19. B. Sibai Imitators of severe preeclampsia Semin Perinatol 33 2009 196 205
20. B.M. Sibai, and C.L. Stella Diagnosis and management of atypical preeclampsia-eclampsia Am J Obstet Gynecol 200 5 2009 481.e1 481.e7
21. K.A. Douglas, and C.W. Redman Eclampsia in the United Kingdom Br Med J 309 1994 1395 1400 (Pubitemid 24351401)